Atherosclerosis is a leading cause of death worldwide, and its mechanisms are still unclear. However, various animal models have significantly advanced our understanding of the mechanisms involved in atherosclerosis and have allowed the evaluation of therapeutic options. The aim of this paper is to review those animal models (i.e
regarding the pathogenesis of this clinical condition have been published and been reviewed elsewhere (Glass and Witztum, 2001) .
Briefly, high plasma low-density lipoprotein (LDL) cholesterol concentrations, especially oxidized LDL (oxLDL) (Ross, 1993; Glass and Witztum, 2001; Libby and Aikawa, 2002) , initiate formation of the atherosclerotic lesion (Ross, 1993) . After initiation, endothelial cells express various adhesion molecules, leading to the attachment of leucocytes to the endothelium. Adhesion molecules such as vascular cell adhesion molecule-1 (VCAM-1), intercellular adhesion molecule-1 (ICAM-1), and E-selectins play major roles in binding, particularly of monocytes and T-lymphocytes, the main cell types found at early atherosclerotic lesions. After their adhesion to endothelial cells, monocytes migrate to the sub-endothelial space, where they differentiate into macrophages. Macrophages express scavenger receptors and take up the cholesterol and oxLDL, subsequently developing into lipid-rich foam cells. The accumulation of foam cells results in the formation of fatty streaks within the vessel wall. These foam cells produce cytokines and reactive oxygen species, which enhance the inflammatory process.
As the process continues, smooth muscle cells immigrate from the medial layer into the intimal or sub-endothelial space where they may proliferate, ingest modified lipoproteins, and contribute to more complex lesions as smooth muscle cells secrete extracellular matrix proteins, leading to the development of fibrous plaque (Ross, 1999) . This phase of the lesion is influenced by a broad range of cellular and humoral responses, such as a chronic inflammatory state (Hansson, 2005 (Hansson, , 2009 , resulting in the narrowing of the aortic lumen. Advanced lesions occur with rupture of the plaque, which allows blood components to come in contact with plaque lipids and tissue factor, resulting in the formation of a thrombus and leading to ischemic symptoms such as myocardial infarction and stroke ( Fig. 1) (Davies and Hollman, 1998; Libby and Aikawa, 2002) .
While atherosclerosis is a multifactorial disease involving a number of genetic and environmental factors, the most common risk factor for the development of this disease is the alteration of cholesterol levels in the blood. For the past two decades, the statin class of cholesterol-lowering drugs has been the first-line therapy for the treatment of hypercholesterolemia (Knopp, 1999; Knopp and Paramsothy, 2006) . Despite their efficacy in lowering cholesterol levels and reducing cardiovascular causes of death, 70% of statintreated patients still experience adverse coronary events (Mohrschladt et al., 2004) . Thus, there has been a significant push toward the development of new therapeutics that target risk factors other than hypercholesterolemia, and that can be used alone or in combination with a statin.
Animal models that help to elucidate the pathogenetic steps and causalities in atherosclerosis play a crucial role in the current search for new therapeutics. A milestone study was published in 1908 when the Russian scientist Alexander Ignatowski demonstrated that atherosclerosis can be induced in rabbits by feeding them milk and egg yolks (Ignatowski, 1908) . Since then, animal models (including mice, rats, guinea pigs, hamsters, avian, swine, and non-human primates) have provided valuable information about diagnostic and therapeutic strategies for atherosclerosis, with extensive investigation of events occurring in the artery wall throughout the course of the disease. This minireview provides information on the advantages and disadvantages of each model organism for atherosclerosis research. 
ANIMAL MODELS OF ATHEROSCLEROSIS Glires
The Glires is a clade consisting of rodents (e.g., mice, rats, hamsters, and guinea pigs) and lagomorphs (e.g., rabbits, hares, and pikas). It should be noted, however, that rabbits are sometimes confused with rodents. In any event, rodents and rabbits are the most commonly used animals for atherosclerosis research.
Rabbits
After the first report of diet-induced atherosclerosis in rabbits by Ignatowski (Ignatowski, 1908) and the subsequent discovery that cholesterol-feeding induces atherosclerosis in rabbits by Chalatov (Anitschkow and Chalatow, 1913) , atheromatic lesions were mainly introduced into rabbits by applying specific diets. Further, among all strains, New Zealand rabbits (with body weights between 2 and 5 kg) are the most popular strain used for atherosclerosis research. More specifically, the Watanabe, St. Tomas, and Houston RT lines are the most important and widely used for study among the New Zealand rabbits (Watanabe, 1980; Kita et al., 1987; Armstrong and Heistad, 1990) .
Several characteristics of the rabbit make it an excellent model for the study of atherosclerosis, including ease in maintaining and handling the animals, as well as their inexpensive upkeep and ready availability. The normal range of plasma cholesterol in the New Zealand white rabbit is low (average = 1.3 mmol/L) (Finking and Hanke, 1997) , but plasma cholesterol can increase two-to eight-fold within the first 20 days after the administration of a cholesterol-rich diet (Bocan et al., 1993) . The atherosclerotic lesions are characterized by an increase in leukocyte immigration, endothelial penetration, and the formation of macrophagederived foam cells in the intima of the large conduit arteries (especially the aortic arch and thoracic aorta), which are similar to human fatty streaks at the early stage of the lesions.
The rabbit has been widely used and thoroughly reviewed as an atherogenesis model (Yanni et al., 2003) . Indeed, different amounts of cholesterol in the diet (Bocan et al., 1993; Kolodgie et al., 1996) , with or without a combination of oils (Kolodgie et al., 1996; Yanni et al., 2003) and specific proteins (Kritchevsky et al., 1977; West et al., 1982; Kritchevsky, 1995) , as well as various durations of experimental studies (Hunt and Duncan, 1985; Rogers and Karnovsky, 1988) , have been used to cause different types of lesions in arteries. A long-duration, low-cholesterol diet causes atherosclerotic lesions with smooth muscle cell penetration and cholesterol deposition, which are similar to that observed in human lesions (Kolodgie et al., 1996) . In contrast, advanced atheromatic lesions are induced with casein, 0.2% cholesterol, and 19% butterfat provided for 6 months to 5 years Roach, 1974, 1976; Adams et al., 1982; West et al., 1982; Rogers and Karnovsky, 1988) ; some studies suggest that the formation of advanced lesions depends on the age of the animal. It was suggested that age is also a critical factor for the lesions, with 3-to 4.5-yearold rabbits exhibiting fibrotic plaques while young rabbits (4 months) do not (Spagnoli et al., 1991) . To induce more advanced lesions, such as a fibrous cap with a high amount of smooth muscle cells in the thoracic and abdominal aorta, a high cholesterol diet must be combined with a single or double balloon injury (Abela et al., 1995; Aikawa et al., 1998; Worthley et al., 2000) . Additionally, pharmacological triggering in combination with balloon injury results in the formation of plaques that are similar to those found in human coronary arteries (Johnstone et al., 2001) .
The generation of genetically altered rabbits in recent years has extensively expanded our understanding of the mechanisms involved in the pathogenesis of atherosclerosis. The lipoprotein disorder rabbit models of familial hypercholesterolemia and familial combined hyperlipidemia (e.g., the St. Thomas' Hospital strains, Watanabe Heritable Hyperlipidemic (WHHL) (a genetic deprivation of functional LDL receptors) (Watanabe, 1980) , and Houston RT (Armstrong and Heistad, 1990) ) enable the assessment of candidate genes for potential use in the treatment of dyslipoproteinemic patients. In these animals, the atherosclerotic process begins in utero (Aliev and Burnstock, 1998) , and the lesions progress with age. Indeed, atherosclerosis occurs even when these rabbits are fed a cholesterol free diet, and this is the same genetic defect seen in patients with familial hypercholesterolemia.
The use of transgenic rabbit models for the elucidation of the mechanisms of atherogenesis provides new insight of great interest. In 1993, Hoeg et al. (Hoeg et al., 1993) generated transgenic rabbits overexpressing human apolipoprotein (apo) A-I and these animals displayed significant decreases in atherosclerotic lesion areas compared to the control group (Duverger et al., 1996) . In 1994, Fan and coworkers generated transgenic rabbits overexpressing human hepatic lipase (Fan et al., 1994) , and the susceptibility of these rabbits to atherosclerosis has been determined (Taylor and Fan, 1997) . In 1996, Hoeg et al. demonstrated that transgenic rabbits overexpressing human lecithin-cholesterol acyl transferase (LCAT) have markedly reduced atherosclerosis when fed a high cholesterol diet (Hoeg et al., 1996) . Analysis of the plasma lipid concentration in human apoB-100 transgenic rabbits has revealed that total plasma cholesterol and triglyceride levels are two-to three-fold higher than those observed in age-, sex-and diet-matched, nontransgenic littermates (Fan et al., 1995; Brousseau and Hoeg, 1999) . However, the levels of high-density lipoprotein (HDL) cholesterol are markedly reduced. The overexpression of lipoprotein lipase (LPL) in transgenic rabbits influences all classes of lipoproteins. These rabbits are highly resistant to diet-induced hypercholesterolemia and atherosclerosis (Fan et al., 2001b) . In 1996, Shen and co-workers revealed that the overexpression of 15-lipoxygenase in monocytes/macrophages protects against lipid deposition in the vessel wall during early atherogenesis (Shen et al., 1996) . Transgenic WHHL rabbits that express human apoA display more extensive advanced atherosclerotic lesions (e.g., atheroma, fibroatheroma, and calcification) compared to controls and a significant increase in the area of sudanophilic lesions in a diet-induced study (Fan et al., 2001a) .
There are several disadvantages that limit the use of rabbits for studying the mechanisms of atherosclerosis. First, it is rare for rabbits to develop advanced lesions with fibrosis, hemorrhage, ulceration, and/or thrombosis, all characteristics of lesions in humans. Although the early lesions of fatty streaks are similar to those in humans, tissue plaques do not develop in the rabbit endothelium, which is a trademark of atherosclerosis in humans (Kolodgie et al., 1996) . Second, in the rabbit, lesions are distributed predominantly in the aortic arch and thoracic aorta, at the origins of intercostal arteries, and (to a lesser extent) in the abdominal aorta. In humans, plaques are more abundant in the abdominal aorta enriched with smooth muscle cells and usually have a fibrous cap (Taylor and Fan, 1997) . Third, a long-term, high cholesterol diet is highly hepatotoxic for the rabbits, which often causes mortality before the end of the study. Fourth, massive inflammation occurs in the body, which does not reflect the pathophysiology in human counterparts. Fifth, the majority of circulating cholesterol in rabbits is transported in HDL (Fig. 2) , while the majority of circulating cholesterol in human is transported in LDL. Finally, antibodies needed to study the pathways involved in inflammation in rabbits are generally not available (Table 1) .
Mice
Generally, mice are resistant to diet-induced atherogenesis. Approximately 70% of the total plasma cholesterol is HDL particles in mice ( Fig. 2) (Fernandez et al., 1999) , which may be due to the lack of the plasma cholesteryl ester transfer protein (CETP). However, due to the hundreds of wellestablished inbred mouse lines, well-defined genetic map, and easily obtainable congenic and recombinant strains, the mouse model is currently the most widely used system to study atherosclerosis despite the anti-atherogenesis phenomenon.
A thorough study demonstrated that early stages of atherosclerotic lesions, such as fatty streaks, can be induced by means of atherogenic diets in C57BL/6J mice after comparison among 10 inbred strains which were fed a diet containing 1.25% (w/w) cholesterol, 0.5% (w/w) cholic acid, and 15% (w/w) fat (Nishina et al., 1990) . In particular, when these animals are fed a very high cholesterol, high-fat diet supplemented with cholic acid for many months, several layers of foam cells appear in the subendothelial space (Breslow, 1996) . Even the total serum cholesterol levels in all ten strains were increased, while plasma triglycerides increased in only three of the 10 and decreased in the other seven strains. More interestingly, atherogenesis was only observed in the AKR/J, DBA/2J, C57L/J, and C57BL/6J strains (Paigen et al., 1985) , which caused difficulties in correlating total plasma cholesterol levels and atherogenesis (Paigen et al., 1985) . It is strongly suggested that the animals' genetic background may play a significant role in their susceptibility to atherogenesis.
For many years, wild-type mice limited their widespread use in atherosclerotic research. However, unlike their wildtype counterparts, transgenic mice provide an excellent tool to study the interactions of gene(s) and the environment in atherogenesis. The mouse apoE gene was the first mouse gene successfully deleted for atherosclerosis research (Plump et al., 1992; Zhang et al., 1992) . Later, several other relevant transgenic murine models, such as LDL receptorknockout (KO) (Véniant et al., 1998) , hepatic lipase-KO (Mezdour et al., 1997) , human apoB100 expression (PurcellHuynh et al., 1995) , and human CETP expression (Marotti et al., 1993) , were also developed. Thus far, 239 strains for atherosclerosis research have been published on the Jax Laboratory webpage. Among them, apoE-KO, LDL receptor-KO, and human apoB100 transgenic mice display marked atherogenesis throughout their arterial tree.
In particular, when these animals are fed a very high cholesterol, high-fat diet supplemented with cholic acid for many months, several layers of foam cells appear in the subendothelial space (Breslow, 1996) . As one of the most extensively used models in atherosclerosis studies, the atherosclerotic lesions in apoE-KO mice have several characteristic features of human atheromas. These mice Figure 2 . Comparisons between lipoprotein cholesterol distribution between several animal models and humans (Fernandez et al., 1999; Ramaswamy et al., 1999; Fernandez and Volek, 2006) . HDL, high-density lipoprotein; LDL, lowdensity lipoprotein; VLDL, very low-density lipoprotein.
spontaneously develop atherosclerosis, and the plaques are widespread and reproducible, particularly those regulating monocyte adherence/chemotaxis and macrophage differentiation/foam cell development. While the sites of lesion are very different from human lesions (i.e., mainly in the aortic root with a foam cell-rich pattern instead of the aortic root and the smooth muscle cell-rich thoracic aorta, which may not have a single definable fibrous cap) and represent xanthomata rather than clinically important advanced lesions. In fact, these mice are models of atherogenesis, not advanced atherosclerosis, and they do not exhibit the single most important event in human atherosclerosis, i.e., plaque rupture leading to vessel occlusion. Various mouse models of plaque rupture have been created in apoE or low-attenuation lipoprotein-receptor KO mice, but whether they represent the same type of plaque rupture is still debated. The advantages of the mouse model include low cost, reproducibility, and the availability of a transgenic technique to dissect the relevant pathologic processes. However, the size of the vessels and hemodynamic factors are very different from those in humans, making it difficult to directly translate results to patients (Table 1) . 
Rats
Like mice, rats do not have plasma CETP either, are generally considered to be resistant to atherogenesis, and~80% of the total plasma cholesterol is in HDL particles (Fig. 2 ) (Fernandez et al., 1999) ; moreover, rats are very efficient in converting cholesterol to bile acids. Notably, certain strains of SHR are particularly susceptible to developing diet-induced, lipid-containing lesions in their arteries (Okamoto et al., 1964) . The lesions in rats are not very similar to those seen in humans; the lipid-containing lesions are generally considered to be residual lesions following an acute arteritis (Table 1) . Rats are generally hypo-responsive to dietary cholesterol. Thus, hyperlipidemia and atherogenesis may only be induced in rats by high cholesterol/high fat diets containing cholic acid and thiouracil (Joris et al., 1983) . Several strains of rats with heritable hyperlipidemia, and some of those associated with atherogenesis, have been described (St. John and Bell, 1991; Russell et al., 1993; Chinellato et al., 1994) . Thus far, however, few transgenic rats (e.g., those overexpressing human CETP in a DS hypertensive strain) have been shown to produce atherosclerosis (Herrera et al., 1999) .
Hamsters
Hamsters, unlike mice and rats but similar to humans, have plasma CETP, and approximately 49% and 48% of the total plasma cholesterol is in HDL and LDL particles, respectively ( Fig. 2) (Fernandez et al., 1999) . It has been reported that male Golden Syrian hamsters develop hypercholesterolemia and early atherosclerosis of fatty streaks in the ascending aorta over a period of 2 months (Nistor et al., 1987) on atherogenic diets. Due to their ease of handling and being more like humans in their response to diet modification than most other rodents, the Syrian hamster has emerged as a viable animal model for atherosclerosis research. Four Golden-Syrian hamster strains have predominantly been used to study diet-induced atherosclerosis. In these strains, no lesions are found in the descending and abdominal aorta, but with continued exposure to a fatty diet, the lesions can progress into complex plaques resembling human lesions. After 1 month of a diet of cholesterol and saturated fat, Syrian hamsters develop subendothelial foam cells, which are precursors of fatty streaks. The atherogenic diet results in a < 200% increase in very low-density lipoprotein (VLDL)/LDL cholesterol, a 20% increase in LDL cholesterol, and a 45% decrease in HDL cholesterol concentrations compared to controls (Nistor et al., 1987) .
Even with the limited data to date, the inbred F1B hamster has been more consistently reported to develop an atherogenic lipoprotein profile than any of the other three outbred strains (i.e., CR, Sasco (Kahlon et al., 1996; Kahlon et al., 1997) , and Harlan hamsters (Lock et al., 2005; Tyburczy et al., 2009) ; for a review, see (Dillard et al., 2010) ). However, due to the inconsistent and unrepeatable results of aortic lesions in response to dietary fat type in recent studies, hamsters are no longer a suitable model for studying dietinduced atherosclerosis (Dillard et al., 2010) (Table 1) .
Guinea pigs
The most striking similarity between guinea pigs and humans is that the majority of their circulating cholesterol is transported in LDL particles (Fig. 2) (Fernandez et al., 1999) . Additionally, guinea pigs resemble human by possessing CEPT, lipoprotein lipase, and LCAT (Grove and Pownall, 1991) . It has been shown that high cholesterol diets induce aortic cholesterol accumulation in guinea pigs and that certain dietary components or drug treatment can reduce the concentrations of cholesterol in their aorta, even in the presence of very high dietary cholesterol (Fernandez and Volek, 2006) . Further, significant atherogenic inflammation with an increase in aortic cytokines has been documented in guinea pigs. The mechanisms of certain drugs affecting triglyceride metabolism can also be explored (Aggarwal et al., 2005; Aggarwal et al., 2006) . However, no advanced atherosclerotic lesions have been observed in guinea pigs (Lynch et al., 1996; Singh et al., 2009) , and the literature considering guinea pigs as surrogates to surgical models is quite sparse. Additionally, antibodies for studying the pathways involved in atherogenic inflammation are lacking.
Avian
Birds are inexpensive to maintain and breed, and some species spontaneously develop atherosclerosis, which can be enhanced by high cholesterol diet. To date, three species have been used for atherosclerosis research: pigeons, Japanese quail, and chickens. The most striking similarities between avian and humans are the characteristics of advanced lesions, such as intimal thickness, necrosis, and infarction (Shih et al., 1983) , making them a popular choice for atherosclerotic study (Table 1) . However, birds have no apoE or apoB48 and do not form chylomicrons when absorbing fat (St Clair, 1998) , which indicates differences in lipid and lipoprotein metabolism between avian and humans. Moreover, birds harbor a variety of viruses that have also been reported to induce atherosclerosis (Lehner et al., 1967; Fabricant et al., 1978; Hajjar et al., 1986; Pătraşcu, 1987) .
Pigeons
Atherosclerosis was first demonstrated in pigeons in 1959 (Clarkson et al., 1959) . The White Carneau (WC) strain develops spontaneous atherosclerosis (St Clair, 1983; Barakat and St Clair, 1985) , and Show Racer (SR) pigeons are resistant to atherogenesis, even when fed a high cholesterol diet (Barakat and St Clair, 1985) . The WC develops macrophage foam cells (Taylor and Lewis, 1986) and atheromas in the thoracic aorta, abdominal aorta, brachiocephalic, iliac, carotid, renal, and coronary arteries (Prichard et al., 1964) .
Quails
A large amount of atherosclerosis-related data were generated in quails after Ojerio et al. (1972) demonstrated dietinduced atherosclerosis and myocardial infarction in this system (Ojerio et al., 1972) . The susceptible Japanese quail strain is responsive to cholesterol feeding (Shih et al., 1983) . Although the majority of circulating cholesterol in quails is transported in HDL particles (Fig. 2) (Hammad et al., 1998) , diet-induced hypercholesterolemia is associated with a significant shift in LDL and VLDL in serum (Ojerio et al., 1972) . Increased levels of plasma cholesterol correlate with an increased frequency and severity of atherosclerotic lesions (Oku et al., 1993) .
These atherosclerotic lesions result in further complications, such as thickened intima, stenosis, necrosis, and infarction. Further, the nature of the lesions is similar to that in humans (Shih et al., 1983) . Altogether, the reproducibility of advanced lesions, along with a well-defined genetic background, makes the atherosclerosis-susceptible Japanese quail attractive in dyslipidemia and atherosclerosis research (Ojerio et al., 1972; Shih et al., 1983; Oku et al., 1993) .
Chickens
Atherosclerosis develops spontaneously in the aorta and coronary arteries of chickens and at an accelerated rate when fed a cholesterol-diet (Dauber, 1944; Dauber et al., 1949) . Further, atherosclerotic lesions can be induced in both abdominal and thoracic aorta in chicks within 2 weeks by cholesterol feeding (Saltykow, 1908) . However, the major limitation of this model in studying human atherosclerosis is that the lesions are not advanced. Thus, chickens better serve as a model for atherogenesis.
Carnivores

Dogs
The cardiovascular physiology and anatomy of dogs are similar to that of humans (Miller et al., 1956) , and dogs also display hematologic and metabolic similarities to humans. Additionally, dogs have been extensively used in studies on blood pressure altering drugs and drug interactions (Keech et al., 1986) , as well as prosthetic devices (Sauvage et al., 1974) . All of these facts make dogs attractive animals for atherosclerosis research. Generally, dogs are resistant to diet-induced atherogenesis, and~75% of their total plasma cholesterol is found in HDL particles (Fig. 2) (Wasan et al., 1998) , which may be due to the lack of plasma CETP. Spontaneous atherosclerosis is rare in dogs; even a high cholesterol diet does not result in the development of advanced atherosclerotic lesions (Mahley et al., 1974) . However, induction of experimental atherosclerosis in dogs is possible with the use of a high fat/high cholesterol (up to 5% w/w) diet deficient in essential fatty acids (Mahley et al., 1974; Butkus et al., 1976) . Hypercholesterolemia and atherosclerosis can also be induced in foxhounds by dietary means (Kent and Whitney, 1982) , though a poor response to dietary cholesterol limits further study (Narayanaswamy et al., 2000) . Regardless of these, some surgical studies have tested venous graft replacements in the dog (Chue et al., 2004) . Additional disadvantages to using dogs as a model organism include the vast array of experimental agents required and certain ethical issues. Dogs also frequently exhibit spontaneous bacteremias and viral infections (Hancock et al., 1980; Nojiri et al., 1987) , which limit their further use for graft responses.
Cats
Cats have not been widely used in studies of atherosclerosis because they are resistant to atherosclerosis. Only a few exceptions report spontaneous and diet-induced atherosclerosis in domestic cats (Wisselink et al., 1994; Ginzinger et al., 1997) .
Swine
Swine are like humans in the fact that the majority of their circulating cholesterol is transported in LDL particles (60% in swine vs 63% in human; 38% is in HDL in swine vs 28% in humans) (Fig. 2) , and their hemodynamic and metabolic values are similar to humans (Liedtke et al., 1975) . The development, morphology, and function of the normal cardiovascular system in swine also closely resembles that of humans (McKenzie et al., 1996) . For instance, the coronary vasculature of a pig heart is nearly identical to that of humans in anatomic distribution, reactivity, and collectoral flow (McKenzie et al., 1996) . The electrophysiologic parameters of pigs also more closely resemble those of man than other models, except the non-human primate (Liedtke et al., 1975; Bowman and Hughes, 1984; Hughes, 1986) . Moreover, cardiovascular surgical procedures using swine have been technically feasible for ventricular assist devices for patients suffering from acute myocardial infarction (Vyavahare et al., 1999; Schoen and Levy, 2009) , vascular stents, and restenosis (David et al., 1998; David et al., 2009) , which make swine a unique surgical model.
In addition, swine develop spontaneous atherosclerosis with increased age (Skold et al., 1966) . Naturally defective pigs with Lpb5 and Lpu1 mutations develop hypercholesterolemia and atherosclerosis in the coronary, iliac, and femoral arteries on low fat cholesterol-free diets (Rapacz et al., 1986; Prescott et al., 1991) . The miniature pig is one of the breeds developed and used for medical research, but an extremely high cholesterol level (4% w/w) is needed to induce advanced atherosclerotic lesions in coronary arteries of miniature pigs (Holvoet et al., 1998) . Regardless of these, the atherosclerotic swine has been extensively characterized over the last 4 decades (Gerrity et al., 1979; Gerrity, 1984; Gerrity et al., 1985; Bell and Gerrity, 1992; El-Khatib et al., 2007) .
Spontaneous rupture was considered an extremely rare or non-existent event in animal models of atherosclerosis. Gerrity et al. examined distal embolism in the swine model to confirm the presence of vulnerable carotid atherosclerotic plaques (Gerrity et al., 2001 ). This swine model of carotid atherosclerosis contains many morphologic features of vulnerable carotid atherosclerotic plaques (e.g., a necrotic core, a thin fibrous cap, and intraplaque hemorrhage), and these features are frequently observed in symptomatic carotid atherosclerotic plaques obtained at endarterectomy. Magnetic resonance (MR) imaging studies have established the association of these carotid plaque characteristics with ischemic events in initially asymptomatic patients. The finding of distal atheroembolism fulfills the functional definition of vulnerable plaque in this animal model. Without the intervening rete mirabile, these emboli would have traveled to the brain and caused infarcts (Gerrity et al., 2001) . Clinical study of carotid artery stent techniques has also been applied in swine (Ishii et al., 2006) . All of these reports have proven pigs to be an excellent model for studying the basic mechanisms, pathophysiology, and progression of atherosclerosis. However, their relatively high cost of maintenance and longer diet-induction time hinder the broader use of swine (Table 1) .
Non-human primates
Non-human primates are attractive models for human diseases; it is plausible that data derived from these animals are more directly applicable to man. Spontaneous atherosclerosis is observed in monkeys (Taylor et al., 1954) , and the development of atherosclerotic lesions and fatal myocardial infarction can be induced in rhesus monkeys fed a high cholesterol diet (Taylor et al., 1954; Andrus and Mann, 1956) . To date, similar observations have been demonstrated by Mann et al. (1953) , Taylor et al. (1959) , Lindsay and Chaikoff (1966) , Armstrong and Warner (1971) and Armstrong and Heistad (1990) to review and characterize dyslipidemia and atherosclerosis in non-human primates.
This abnormal lipid profile is associated with the development of extensive atherosclerotic lesions in the aorta and all its major branches, including the coronary and cerebral vessels. Further, these lesions are similar to those seen in humans. Recently familial LDL receptor deficiency with atherosclerosis has been reported in rhesus monkey (Scanu et al., 1988; Kusumi et al., 1993) . Hyper-and hyporesponsiveness to a cholesterol diet has also been reported in monkey species (Clarkson et al., 1976) . The location of atheromas varies among different strains of monkeys. The most interesting finding from Dr. Geary's research has been the tremendous involvement of remodeling to favorable responses to angioplasty using cynomolgus macaques (Geary et al., 1996) . However, the complications of serious chronic kidney disease are the outcomes of atherosclerosis research in New World monkeys, which modulates both their lipoprotein metabolism and their atherosclerosis (Clarkson et al., 1976) , and has limited the use of non-human primates in such research. Patients with chronic kidney disease develop accelerated atherosclerosis and are at high risk of premature death from cardiovascular disease (Go et al., 2004 (Go et al., , 2006 Kovesdy et al., 2006) . Aside from the high cost of experiments and difficulties in handling, ethical issues also hamper the usage of non-human primates for study (Table 1) .
INSIGHT AND PERSPECTIVE
We are faced with the challenge of the growing incidence/ prevalence of cardiovascular diseases in humans. Over the past century, a variety of experimental procedures have been used to investigate the pathophysiology of one of these diseases, atherosclerosis. As a result, laboratory animals have been extensively used in atherosclerosis research. Looking ahead, transgenic animals are expected to shed light on the molecular pathogenesis of atherosclerosis by elucidating the cause-and-effect relationships in lesion initiation and progression. Regardless, all of the accomplishments listed above have substantially enhanced our understanding of this disease.
"Cholesterol theory" was one of the first hypotheses and still remains at the center of almost all research activity in this field. Cholesterol-lowering agents, particularly the statins (Moghadasian, 1999) , have been extremely promising. However, studies indicate that reduction of plasma cholesterol levels should not be the only tactic in the treatment or prevention of atherosclerotic vascular disease. Our understanding of the process of atherosclerosis lesions is still incomplete. Oxidative stress (Witztum and Steinberg, 1991) , inflammation (Ross, 1999) , hyperhomocyst(e)inemia (Moghadasian et al., 1997) , infection (Chlamydia pneumoniae) (Fong, 2000) , and other emerging risk factors (e.g., diabetic atherosclerosis (Grundy et al., 2002) ) should be carefully considered in the management of this potentially fatal disease. The current established models and new emerging models will provide useful approaches for studying the mechanism(s) of disease progression, as well as serve as valuable tools for evaluating therapeutic options.
